Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Early pregnancy blood pressure patterns tied to hypertension risk years later
Researchers show certain blood pressure patterns during the first 20 weeks of pregnancy were more likely to develop into hypertension later in life.
Heart Rhythm Society legislative advocacy group raising funds for electrophysiology
This week, Heart Rhythm Advocates announced its establishment and called on cardiologists and EPs to support its efforts with membership and joining committees to guide efforts.
Key takeaways from ACC.25: Advances in cardiovascular science
Former American College of Cardiology president Hadley Wilson, MD, executive vice chair of Atrium Health Sanger Heart and Vascular Institute, explains his main takeaway messages from the ACC 2025 late-breaking trials.
New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS
Two separate studies at ACC.25 explored data from the EARLY TAVR trial. One analysis included stroke findings that surprised researchers.
Dapagliflozin improves outcomes for elderly TAVR patients with heart failure
The positive data were presented as part of a late-breaking clinical trial at ACC.25 in Chicago. One cardiologist on stage for the presentation said these findings will impact the way he manages certain TAVR patients.

Women at greater risk of adverse outcomes following PCI

Women are at an increased risk of adverse events following percutaneous coronary intervention (PCI), according to new findings published in the Journal of the American College of Cardiology.

Medical groups urge caution when using hydroxychloroquine, azithromycin to treat COVID-19 patients with CVD

Healthcare providers should use caution when considering the treatment of COVID-19 patients with hydroxychloroquine and azithromycin if the patients have cardiovascular disease.

How should physicians treat STEMI patients with COVID-19? A new study aims to find out

A new international research study will focus on treatment strategies and outcomes of ST-segment elevation myocardial infarction (STEMI) patients with known or suspected COVID-19.

Warfarin use boosts risk of hemorrhagic stroke among end-stage kidney patients with AFib

Warfarin use does not reduce the risk of stroke for end-stage renal disease (ESRD) patients with AFib, according to a new meta-analysis published in JAMA Network Open. It does, however, lead to an increased risk of hemorrhagic stroke.

Hospital testing hydroxychloroquine on coronavirus patients notes serious side effects

A French hospital testing the effectiveness of hydroxychloroquine on COVID-19 patients had to immediately stop testing on one patient due to the risk of significant cardiac side effects.

AAMC offering clinicians COVID-19 guidance from academic medical centers

Healthcare providers have a fresh online resource to consult for emerging best practices on the treatment and management of COVID-19.

Delays, shortages & confusion: New survey details challenges U.S. hospitals face during COVID-19 pandemic

U.S. hospitals are facing numerous challenges as they work to combat the continued spread of COVID-19, according to a new government survey of more than 300 hospital administrators.

Hospitals seeing ‘a previously unimaginable shift’ due to COVID-19—are patients afraid to seek medical attention?

As COVID-19 continues to keep healthcare providers busy, fewer patients appear to be seeking care for other serious issues, including cardiovascular complications such as heart attack and stroke.

Clinical

Early pregnancy blood pressure patterns tied to hypertension risk years later

Heart Rhythm Society legislative advocacy group raising funds for electrophysiology

Key takeaways from ACC.25: Advances in cardiovascular science

New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS

Dapagliflozin improves outcomes for elderly TAVR patients with heart failure